Abstract
Background
The visual prognosis of submacular hemorrhages caused by a retinal arterial macroaneurysm (RAM) is poor if left untreated. The use of recombinant tissue plasminogen activator (rtPA) has frequently been reported to displace submacular hemorrhages from the foveal area in patients with age-related macular degeneration. This study aims to investigate the results of displacement of recent-onset submacular hemorrhages due to RAM.
Methods
Institutional retrospective interventional case series of 12 patients with macular hemorrhage due to RAM, who underwent pars plana vitrectomy (PPV); followed in 11 by submacular injection of rtPA and gas tamponade. The main outcome measures were displacement of the hemorrhage, complication rate, and visual acuity at 1 month after surgery and at the last follow-up visit.
Results
One month after surgery, the hemorrhage had been successfully displaced in ten out of 11 patients. In these ten patients, visual acuity (VA) increased by a mean of 1.2 logMAR at 1 month after surgery. At the last follow-up visit, the mean increase was 1.5 logMAR. Complications consisted of a vitreous hemorrhage and hyphema, retinal detachment, a new submacular hemorrhage, and vitreous hemorrhage after argon laser retinal photocoagulation of the RAM.
Conclusions
PPV with submacular rtPA and gas injection may successfully displace a recently developed submacular hemorrhage in patients with RAM, with a marked improvement in VA that is likely to be greater than if left untreated.
Similar content being viewed by others
References
Rabb MF, Gagliano DA, Teske MP (1988) Retinal arterial macroaneurysms. Surv Ophthalmol 33:73–96
Glatt H, Machemer R (1982) Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 94:762–773
Toth CA, Morse LS, Hjelmeland LM, Landers MB III (1991) Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 109:723–729
Tonotsuka T, Imai M, Saito K, Iijima H (2003) Visual prognosis for symptomatic retinal arterial macroaneurysm. Jpn J Ophthalmol 47:498–502
Heriot WJ (1996) Intravitreal gas and TPA: an outpatient procedure for submacular hemorrhage. American Academy of Ophthalmology Annual Vitreoretinal Update. 1996 BC. Ref Type: Conference Proceeding
Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ (2007) Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina 27:321–328
Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, Blodi BA, Elner SG (1999) Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 106:1900–1906
Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG (2010) Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 248:5–11
Humayun M, Lewis H, Flynn HW Jr, Sternberg P Jr, Blumenkranz MS (1998) Management of submacular hemorrhage associated with retinal arterial macroaneurysms. Am J Ophthalmol 126:358–361
Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y (1998) Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 116:1326–1332
Cakir M, Cekic O, Yilmaz OF (2010) Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator. Eur J Ophthalmol 20:565–571
Wu TT, Sheu SJ (2005) Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm. J Ocul Pharmacol Ther 21:62–67
Peyman GA, Nelson NC Jr, Alturki W, Blinder KJ, Paris CL, Desai UR, Harper CA III (1991) Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg 22:575–582
Nakamura H, Hayakawa K, Sawaguchi S, Gaja T, Nagamine N, Medoruma K (2008) Visual outcome after vitreous, sub-internal limiting membrane, and/or submacular hemorrhage removal associated with ruptured retinal arterial macroaneurysms. Graefes Arch Clin Exp Ophthalmol 246:661–669
Mizutani T, Yasukawa T, Ito Y, Takase A, Hirano Y, Yoshida M, Ogura Y (2011) Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 249:1153–1157
Zhao P, Hayashi H, Oshima K, Nakagawa N, Ohsato M (2000) Vitrectomy for macular hemorrhage associated with retinal arterial macroaneurysm. Ophthalmology 107:613–617
Buhl M, Scheider A, Schonfeld CL, Kampik A (1999) Intra-vitreal rt-PA and gas introduction in submacular hemorrhage. Ophthalmologe 96:792–796
Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A, N S (2007) Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection. Retina 27:329–334
Yang PM, Kuo HK, Kao ML, Chen YJ, Tsai HH (2005) Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator. Chang Gung Med J 28:852–859
Holladay JT (2004) Visual acuity measurements. J Cataract Refract Surg 30:287–290
Benner JD, Hay A, Landers MB III, Hjelmeland LM, Morse LS (1994) Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration. Ophthalmology 101:672–681
Kamei M, Estafanous M, Lewis H (2000) Tissue plasminogen activator in the treatment of vitreoretinal diseases. Semin Ophthalmol 15:44–50
Sampangi R, Chandrakumar HV, Somashekar SE, Joshi GR, Ganesh S (2011) SD-OCT to differentiate traumatic submacular hemorrhage types using automatic three-dimensional segmentation analysis. Ophthalmic Surg Lasers Imaging 42 Online:e32–e36
Shah VA, Poulose A, Cassell M, Sabates NR (2010) Spectral domain optical coherence tomography findings of retinal macroaneurysm. Ophthalmic Surg Lasers Imaging 9–3:1–4
Iijima H, Satoh S, Tsukahara S (1998) Nd:YAG laser photodisruption for preretinal hemorrhage due to retinal macroaneurysm. Retina 18:430–434
Rennie CA, Newman DK, Snead MP, Flanagan DW (2001) Nd:YAG laser treatment for premacular subhyaloid haemorrhage. Eye (Lond) 15:519–524
Arias L, Mones J (2010) Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration. Clin Ophthalmol 4:67–72
Haupert CL, McCuen BW, Jaffe GJ, Steuer ER, Cox TA, Toth CA, Fekrat S, Postel EA (2001) Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 131:208–215
Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC (2004) Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 111:1201–1208
Singh RP, Patel C, Sears JE (2006) Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator. Br J Ophthalmol 90:429–431
Thompson JT, Sjaarda RN (2005) Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement. Trans Am Ophthalmol Soc 103:98–107
Treumer F, Klatt C, Roider J, Hillenkamp J (2010) Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage. Br J Ophthalmol 94:48–53
Sandhu SS, Manvikar S, Steel DH (2010) Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab. Clin Ophthalmol 4:637–642
Lewis H (1994) Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 118:559–568
Bopp S (2007) Retinal arterial macroaneurysms. In: Joussen AM, Gardner TW, Kirchhof B, Ryan SJ (eds) Retinal Vascular Disease. Springer, Berlin Heidelberg New York, pp 543–560
Kamei M, Misono K, Lewis H (1999) A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 128:739–746
Lincoff H, Kreissig I, Stopa M, Uram D (2008) A 40 degrees gaze down position for pneumatic displacement of submacular hemorrhage: clinical application and results. Retina 28:56–59
Stopa M, Lincoff A, Lincoff H (2007) Analysis of forces acting upon submacular hemorrhage in pneumatic displacement. Retina 27:370–374
Acknowledgments
We would like to thank L. Spielberg (The Rotterdam Eye Hospital) for manuscript editing.
Funding/Support
1) The Rotterdam Eye Hospital Flieringa Research Foundation, Rotterdam, The Netherlands
2) Royal Visio, Rotterdam, The Netherlands
Financial disclosure
The last author J.C. van Meurs is the partial owner of a patent: vibration device for tissue release, with Dutch Ophthalmic Research Center [DORC], Zuidland, The Netherlands, one prototype. The other authors have no financial disclosures.
Author information
Authors and Affiliations
Corresponding author
Additional information
All authors have full control of all primary data and agree to allow Graefes Archive for Clinical and Experimental Ophthalmology to review their data upon request.
Rights and permissions
About this article
Cite this article
van Zeeburg, E.J.T., Cereda, M.G. & van Meurs, J.C. Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm. Graefes Arch Clin Exp Ophthalmol 251, 733–740 (2013). https://doi.org/10.1007/s00417-012-2116-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2116-3